Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) CEO Safi R. Bahcall continues to pick up shares.

Bahcall disclosed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE